Shares for the region’s newest public company, Sienna Biopharmaceuticals, continued to climb after the stock jumped nearly 30 percent following its July 27 initial public offering. The Westlake Village biotechnology company closed with a big gain after it raised $65 million in its IPO, pricing the 4.33 million shares it offered at $15. Underwriters, including…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
